Quality assessment for clinical proteomics

Clinical Biochemistry

Volumn 46, Issue 6, 2013, Pages 411-420

  Tabb, David L ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Mass spectrometry profiling; Polyacrylamide gel electrophoresis; Proteomics; Quality assessment; Quality by design; Quality control; Repeatability; Reproducibility; Selected reaction monitoring

Indexed keywords

PEPTIDE;

AMINO ACID SEQUENCE; ANALYTIC METHOD; CHROMATOGRAPHY; DATA BASE; DECISION MAKING; GEL ELECTROPHORESIS; HUMAN; INFORMATION PROCESSING; INVENTORY CONTROL; MASS SPECTROMETRY; PIPELINE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; QUALITY CONTROL; REVIEW; SEPARATION TECHNIQUE; STRUCTURAL PROTEOMICS; TANDEM MASS SPECTROMETRY; BIOLOGY; DIAGNOSTIC PROCEDURE; GENE EXPRESSION PROFILING; LIQUID CHROMATOGRAPHY; MEDICAL TECHNOLOGY; PROCEDURES; METHODOLOGY;

CHROMATOGRAPHY, LIQUID; CLINICAL LABORATORY TECHNIQUES; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; MEDICAL LABORATORY SCIENCE; PROTEOMICS; QUALITY CONTROL; TANDEM MASS SPECTROMETRY;

EID: 84885675848     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.12.003     Document Type: Review

References (72)

1. Repeatability. IUPAC compendium of chemical terminology [internet] 2012, IUPAC, Research Triagle Park, NC, Available from: http://goldbook.iupac.org/R05293.html. 2.1.0 ed. M. Nič, J. Jirát, B. Košata, A. Jenkins, A. McNaught (Eds.).
2. Rathore A.S., Winkle H. Quality by design for biopharmaceuticals. Nat Biotechnol Jan. 2009, 27(1):26-34.
3. Yu L.X. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res Apr. 2008, 25(4):781-791.
4. Del Val I.J., Kontoravdi C., Nagy J.M. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns. Biotechnol Prog Dec. 2010, 26(6):1505-1527.
5. Ransohoff D.F. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer Apr. 2004, 4(4):309-314.
6. McGuire J.N., Overgaard J., Pociot F. Mass spectrometry is only one piece of the puzzle in clinical proteomics. Brief Funct Genomic Proteomic Jan. 2008, 7(1):74-83.
7. Karp N.A., Lilley K.S. Design and analysis issues in quantitative proteomics studies. Proteomics Sep. 2007, 7(Suppl. 1):42-50.
8. Mischak H., Apweiler R., Banks R.E., Conaway M., Coon J., Dominiczak A., et al. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl Feb. 2007, 1(2):148-156.
9. Sarzotti-Kelsoe M., Cox J., Cleland N., Denny T., Hural J., Needham L., et al. Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials. PLoS Med May 26 2009, 6(5):e1000067.
10. Klie S., Martens L., Vizcaíno J.A., CÔté R., Jones P., Apweiler R., et al. Analyzing large-scale proteomics projects with latent semantic indexing. J Proteome Res Jan. 2008, 7(1):182-191.
11. Bell A.W., Deutsch E.W., Au C.E., Kearney R.E., Beavis R., Sechi S., et al. A HUPO test sample study reveals common problems in mass spectrometry-based proteomics. Nat Methods Jun. 2009, 6(6):423-430.
12. Friedman D.B., Andacht T.M., Bunger M.K., Chien A.S., Hawke D.H., Krijgsveld J., et al. The ABRF Proteomics Research Group studies: educational exercises for qualitative and quantitative proteomic analyses. Proteomics Apr. 2011, 11(8):1371-1381.
13. Mann M. Comparative analysis to guide quality improvements in proteomics. Nat Methods Oct. 2009, 6(10):717-719.
14. Lescuyer P., Hochstrasser D., Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery?. J Proteome Res Sep. 2007, 6(9):3371-3376.
15. Petricoin E.F., Ardekani A.M., Hitt B.A., Levine P.J., Fusaro V.A., Steinberg S.M., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet Feb. 16 2002, 359(9306):572-577.
16. Baggerly K.A., Morris J.S., Edmonson S.R., Coombes K.R. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst Feb. 16 2005, 97(4):307-309.
17. Gentleman R. Reproducible research: a bioinformatics case study. Stat Appl Genet Mol Biol 2005, 4. [Article 2].
18. Martens L., Hermjakob H. Proteomics data validation: why all must provide data. Mol Biosyst Aug. 2007, 3(8):518-522.
19. Rodriguez H., Snyder M., Uhlén M., Andrews P., Beavis R., Borchers C., et al. Recommendations from the 2008 international summit on proteomics data release and sharing policy: the Amsterdam principles. J Proteome Res Jul. 2009, 8(7):3689-3692.
20. Cottingham K. MCP ups the ante by mandating raw-data deposition. J Proteome Res Nov. 2009, 8(11):4887-4888.
21. Kinsinger C.R., Apffel J., Baker M., Bian X., Borchers C.H., Bradshaw R., et al. Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles). Mol Cell Proteomics Dec. 2011, 10(12). [O111.015446].
22. Martens L., Chambers M., Sturm M., Kessner D., Levander F., Shofstahl J., et al. mzML-a community standard for mass spectrometry data. Mol Cell Proteomics Jan. 2011, 10(1). [R110.000133].
23. Jones A.R., Eisenacher M., Mayer G., Kohlbacher O., Siepen J., Hubbard S.J., et al. The mzIdentML data standard for mass spectrometry-based proteomics results. Mol Cell Proteomics Jul. 2012, 11(7). [M111.014381].
24. Deutsch E.W., Chambers M., Neumann S., Levander F., Binz P.-A., Shofstahl J., et al. TraML-a standard format for exchange of selected reaction monitoring transition lists. Mol Cell Proteomics Apr. 2012, 11(4). [R111.015040].
25. Köcher T., Pichler P., Swart R., Mechtler K. Quality control in LC-MS/MS. Proteomics Mar. 2011, 11(6):1026-1030.
26. Apweiler R., Aslanidis C., Deufel T., Gerstner A., Hansen J., Hochstrasser D., et al. Approaching clinical proteomics: current state and future fields of application in fluid proteomics. Clin Chem Lab Med 2009, 47(6):724-744.
27. Robinson A.A., Westbrook J.A., English J.A., Borén M., Dunn M.J. Assessing the use of thermal treatment to preserve the intact proteomes of post-mortem heart and brain tissue. Proteomics Oct. 2009, 9(19):4433-4444.
28. Sköld K., Svensson M., Norrman M., Sjögren B., Svenningsson P., Andrén P.E. The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators. Proteomics Dec. 2007, 7(24):4445-4456.
29. Finnie C., Svensson B. Proteolysis during the isoelectric focusing step of two-dimensional gel electrophoresis may be a common problem. Anal Biochem Dec. 15 2002, 311(2):182-186.
30. Grassl J., Westbrook J.A., Robinson A., Borén M., Dunn M.J., Clyne R.K. Preserving the yeast proteome from sample degradation. Proteomics Oct. 2009, 9(20):4616-4626.
31. Picotti P., Aebersold R., Domon B. The implications of proteolytic background for shotgun proteomics. Mol Cell Proteomics Sep. 2007, 6(9):1589-1598.
32. Tabb D.L., Vega-Montoto L., Rudnick P.A., Variyath A.M., Ham A.-J.L., Bunk D.M., et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J Proteome Res Feb. 5 2010, 9(2):761-776.
33. Russell W.K., Park Z.Y., Russell D.H. Proteolysis in mixed organic-aqueous solvent systems: applications for peptide mass mapping using mass spectrometry. Anal Chem Jun. 1 2001, 73(11):2682-2685.
34. Schwartz S.A., Reyzer M.L., Caprioli R.M. Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J Mass Spectrom Jul. 2003, 38(7):699-708.
35. Yildiz P.B., Shyr Y., Rahman J.S.M., Wardwell N.R., Zimmerman L.J., Shakhtour B., et al. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol Oct. 2007, 2(10):893-901.
36. Thongboonkerd V., Chutipongtanate S., Kanlaya R. Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J Proteome Res Jan. 2006, 5(1):183-191.
37. Fuxius S., Eravci M., Broedel O., Weist S., Mansmann U., Eravci S., et al. Technical strategies to reduce the amount of "false significant" results in quantitative proteomics. Proteomics May 2008, 8(9):1780-1784.
38. Molloy M.P., Brzezinski E.E., Hang J., McDowell M.T., VanBogelen R.A. Overcoming technical variation and biological variation in quantitative proteomics. Proteomics Oct. 2003, 3(10):1912-1919.
39. Horgan G.W. Sample size and replication in 2D gel electrophoresis studies. J Proteome Res Jul. 2007, 6(7):2884-2887.
40. Hunt S.M.N., Thomas M.R., Sebastian L.T., Pedersen S.K., Harcourt R.L., Sloane A.J., et al. Optimal replication and the importance of experimental design for gel-based quantitative proteomics. J Proteome Res Jun. 2005, 4(3):809-819.
41. Karp N.A., McCormick P.S., Russell M.R., Lilley K.S. Experimental and statistical considerations to avoid false conclusions in proteomics studies using differential in-gel electrophoresis. Mol Cell Proteomics Aug. 2007, 6(8):1354-1364.
42. Jackson D., Herath A., Swinton J., Bramwell D., Chopra R., Hughes A., et al. Considerations for powering a clinical proteomics study: normal variability in the human plasma proteome. Proteomics Clin Appl Mar. 2009, 3(3):394-407.
43. Pedreschi R., Hertog M.L.A.T.M., Carpentier S.C., Lammertyn J., Robben J., Noben J.-P., et al. Treatment of missing values for multivariate statistical analysis of gel-based proteomics data. Proteomics Apr. 2008, 8(7):1371-1383.
44. Petrak J., Ivanek R., Toman O., Cmejla R., Cmejlova J., Vyoral D., et al. Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics May 2008, 8(9):1744-1749.
45. Coombes K.R., Fritsche H.A., Clarke C., Chen J.-N., Baggerly K.A., Morris J.S., et al. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin Chem Oct. 2003, 49(10):1615-1623.
46. Albrethsen J. Reproducibility in protein profiling by MALDI-TOF mass spectrometry. Clin Chem May 2007, 53(5):852-858.
47. Stoeckli M., Chaurand P., Hallahan D.E., Caprioli R.M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med Apr. 2001, 7(4):493-496.
48. Bellew M., Coram M., Fitzgibbon M., Igra M., Randolph T., Wang P., et al. A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC-MS. Bioinformatics Aug. 1 2006, 22(15):1902-1909.
49. Piening B.D., Wang P., Bangur C.S., Whiteaker J., Zhang H., Feng L.-C., et al. Quality control metrics for LC-MS feature detection tools demonstrated on Saccharomyces cerevisiae proteomic profiles. J Proteome Res Jul. 2006, 5(7):1527-1534.
50. Fang Y., Robinson D.P., Foster L.J. Quantitative analysis of proteome coverage and recovery rates for upstream fractionation methods in proteomics. J Proteome Res Apr. 5 2010, 9(4):1902-1912.
51. Slebos R.J.C., Brock J.W.C., Winters N.F., Stuart S.R., Martinez M.A., Li M., et al. Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res Dec. 2008, 7(12):5286-5294.
52. Jaitly N., Monroe M.E., Petyuk V.A., Clauss T.R.W., Adkins J.N., Smith R.D. Robust algorithm for alignment of liquid chromatography-mass spectrometry analyses in an accurate mass and time tag data analysis pipeline. Anal Chem Nov. 1 2006, 78(21):7397-7409.
53. Rudnick P.A., Clauser K.R., Kilpatrick L.E., Tchekhovskoi D.V., Neta P., Blonder N., et al. Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Mol Cell Proteomics Feb. 2010, 9(2):225-241.
54. Ma Z.-Q., Polzin K.O., Dasari S., Chambers M.C., Schilling B., Gibson B.W., et al. QuaMeter: multivendor performance metrics for LC-MS/MS proteomics instrumentation. Anal Chem Jul. 17 2012, 84(14):5845-5850.
55. Ma Z.-Q., Chambers M.C., Ham A.-J.L., Cheek K.L., Whitwell C.W., Aerni H.-R., et al. ScanRanker: quality assessment of tandem mass spectra via sequence tagging. J Proteome Res Jul. 1 2011, 10(7):2896-2904.
56. Wong J.W.H., Sullivan M.J., Cartwright H.M., Cagney G. msmsEval: tandem mass spectral quality assignment for high-throughput proteomics. BMC Bioinformatics Feb. 9 2007, 8:51.
57. Nesvizhskii A.I., Roos F.F., Grossmann J., Vogelzang M., Eddes J.S., Gruissem W., et al. Dynamic spectrum quality assessment and iterative computational analysis of shotgun proteomic data: toward more efficient identification of post-translational modifications, sequence polymorphisms, and novel peptides. Mol Cell Proteomics Apr. 2006, 5(4):652-670.
58. Beer I., Barnea E., Ziv T., Admon A. Improving large-scale proteomics by clustering of mass spectrometry data. Proteomics Apr. 2004, 4(4):950-960.
59. Pan C., Kora G., Tabb D.L., Pelletier D.A., McDonald W.H., Hurst G.B., et al. Robust estimation of peptide abundance ratios and rigorous scoring of their variability and bias in quantitative shotgun proteomics. Anal Chem Oct. 15 2006, 78(20):7110-7120.
60. Hill E.G., Schwacke J.H., Comte-Walters S., Slate E.H., Oberg A.L., Eckel-Passow J.E., et al. A statistical model for iTRAQ data analysis. J Proteome Res Aug. 2008, 7(8):3091-3101.
61. Oberg A.L., Mahoney D.W., Eckel-Passow J.E., Malone C.J., Wolfinger R.D., Hill E.G., et al. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res Jan. 2008, 7(1):225-233.
62. Mahoney D.W., Therneau T.M., Heppelmann C.J., Higgins L., Benson L.M., Zenka R.M., et al. Relative quantification: characterization of bias, variability and fold changes in mass spectrometry data from iTRAQ-labeled peptides. J Proteome Res Sep. 2 2011, 10(9):4325-4333.
63. Addona T.A., Abbatiello S.E., Schilling B., Skates S.J., Mani D.R., Bunk D.M., et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol Jul. 2009, 27(7):633-641.
64. Xia J.Q., Sedransk N., Feng X. Variance component analysis of a multi-site study for the reproducibility of multiple reaction monitoring measurements of peptides in human plasma. PLoS One Jan. 26 2011, 6(1):e14590.
65. Prakash A., Rezai T., Krastins B., Sarracino D., Athanas M., Russo P., et al. Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays. J Proteome Res Dec. 3 2010, 9(12):6678-6688.
66. Prakash A., Rezai T., Krastins B., Sarracino D., Athanas M., Russo P., et al. Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies. J Proteome Res Aug. 3 2012, 11(8):3986-3995.
67. Stead D.A., Paton N.W., Missier P., Embury S.M., Hedeler C., Jin B., et al. Information quality in proteomics. Brief Bioinform Mar. 2008, 9(2):174-188.
68. Taylor R., Dance J., Prince J. Metriculator: quality assessment for mass spectrometry based proteomics. Proceedings of the 8th Annual Conference of the United States Human Proteomics Organization [Internet]. San Francisco, CA 2012, [page Career Development: Technologies. Available from: http://www.hupo.org/flipbook/files/inc/923710546.pdf].
69. Pichler P., Mazanek M., Dusberger F., Weilnböck L., Huber C.G., Stingl C., et al. SIMPATIQCO: a server-based software suite which facilitates monitoring the time course of LC-MS performance metrics on Orbitrap instruments. J Proteome Res Nov. 2 2012, 11(11):5540-5547.
70. Zenka R.M., Johnson K.L., Bergen H.R.I. Exploring proteomics metadata using Spotfire and a companion user interface. Proceedings of the 59th ASMS Conference on Mass Spectrometry and Allied Topics [Internet]. Denver, CO 2011, [page ThP22: 2745. Available from: http://informatics.mayo.edu/svn/trunk/mprc/swift/spotfire_companion_asms_2011.pdf].
71. Sutton J., Richmond T., Shi X., Athanas M., Ptak C., Gerszten R., et al. Performance characteristics of an FT MS-based workflow for label-free differential MS analysis of human plasma: standards, reproducibility, targeted feature investigation, and application to a model of controlled myocardial infarction. Proteomics Clin Appl Jun. 2008, 2(6):862-881.
72. Prakash A., Piening B., Whiteaker J., Zhang H., Shaffer S.A., Martin D., et al. Assessing bias in experiment design for large scale mass spectrometry-based quantitative proteomics. Mol Cell Proteomics Oct. 2007, 6(10):1741-1748.